Literature DB >> 10928461

Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.

S Middeldorp1, J C Meijers, A E van den Ende, A van Enk, B N Bouma, G Tans, J Rosing, M H Prins, H R Büller.   

Abstract

Combined oral contraceptives (OC) are known to increase the risk of venous thromboembolism. The aim of this randomized, cycle-controlled, cross-over study in 28 healthy volunteers was to assess potential differences between the effects of an OC containing 150 microg levonorgestrel (as representative of the so-called second generation OC) and an OC containing 150 microg desogestrel (as representative of the third generation OC) in combination with 30 microg ethinylestradiol on several coagulation factors and markers of thrombin formation. All participants used each OC for two cycles, and were switched to the other OC after a washout period of two menstrual cycles. The plasma concentrations of factors II, VII, X, and fibrinogen significantly increased during use of both the levonorgestrel- and desogestrel-containing OC's. The plasma concentrations of factor VIII increased, and of factor V decreased, changes which only reached statistical significance during the use of the desogestrel-containing OC. During exposure to the desogestrel-containing OC, as compared with the levonorgestrel-containing OC, both factor VII and factor II showed a greater increase (FVII: 32% and 12% respectively; p <0.0001; FII: 16% and 12% respectively; p = 0.048), whereas factor V showed a greater decrease (-11% and -3% respectively; p = 0.010). Only one of the markers for ongoing coagulation (prothrombin fragment 1+2) showed a significant increase during OC use, whereas concentrations of thrombin-antithrombin complexes and soluble fibrin remained unchanged. For these markers, there was no difference between the tested OC's. We conclude that there are differences between the effects of levonorgestrel and desogestrel-containing OC's on some coagulation factors. Whether these changes provide a biological explanation for the reported differences in venous thromboembolic risk is as yet unclear. The real challenge now becomes to define a pattern of changes in the various systems which, if affected simultaneously, may tip the hemostatic balance towards a prethrombotic state and may lead to overt clinical venous thromboembolism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928461

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  25 in total

Review 1.  A Systematic Review and Meta-analysis of the Adverse Effects of Levonorgestrel Emergency Oral Contraceptive.

Authors:  Nattawut Leelakanok; Janthima Methaneethorn
Journal:  Clin Drug Investig       Date:  2020-05       Impact factor: 2.859

2.  Image Diagnosis: Splenic Infarction Associated with Oral Contraceptive Pills in a Healthy Young Woman.

Authors:  Al-Ola Abdallah; Varinder Kaur; Fade Mahmoud; Pooja Motwani
Journal:  Perm J       Date:  2017

Review 3.  Estrogen and thrombosis: A bench to bedside review.

Authors:  Mouhamed Yazan Abou-Ismail; Divyaswathi Citla Sridhar; Lalitha Nayak
Journal:  Thromb Res       Date:  2020-05-11       Impact factor: 3.944

4.  Extensive Thrombus and Brain Microabscesses After Sleeve Gastrectomy.

Authors:  Grace Faith Chao; Sameer Hirji; Scott Alan Shikora
Journal:  J Radiol Case Rep       Date:  2018-03-31

5.  Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.

Authors:  Pansakorn Tanratana; Paul Ellery; Pamela Westmark; Alan E Mast; John P Sheehan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-02       Impact factor: 8.311

Review 6.  Metabolic effects of contraceptive steroids.

Authors:  Regine Sitruk-Ware; Anita Nath
Journal:  Rev Endocr Metab Disord       Date:  2011-06       Impact factor: 6.514

7.  The plasma hemostatic proteome: thrombin generation in healthy individuals.

Authors:  K Brummel-Ziedins; C Y Vossen; F R Rosendaal; K Umezaki; K G Mann
Journal:  J Thromb Haemost       Date:  2005-07       Impact factor: 5.824

Review 8.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

9.  The effects of obesity on venous thromboembolism: A review.

Authors:  Genyan Yang; Christine De Staercke; W Craig Hooper
Journal:  Open J Prev Med       Date:  2012-11

10.  The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study.

Authors:  A van Hylckama Vlieg; F M Helmerhorst; J P Vandenbroucke; C J M Doggen; F R Rosendaal
Journal:  BMJ       Date:  2009-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.